机译:丙型肝炎病毒基因型3感染患者的抗性分析与治疗结果意大利网络vironet-c-c
Univ Roma Tor Vergata Dept Expt Med Via Montpellier 1 I-00133 Rome Italy;
Univ Roma Tor Vergata Dept Expt Med Via Montpellier 1 I-00133 Rome Italy;
Univ Hosp Rome Tor Vergata Infect Dis Rome Italy;
St Andrea Hosp La Sapienza Infect Dis Rome Italy;
Univ Hosp Rome Tor Vergata Hepatol Unit Rome Italy;
IRCCS Policlin Fdn San Matteo Microbiol &
Virol Dept Mol Virol Unit Pavia Italy;
Univ Hosp Messina Dept Internal Med Messina Italy;
IRCCS Div Infect Dis Osped San Raffaele Milan Italy;
Univ Campania L Vanvitelli Lab Identificat Prognost Factors Response Treatme Naples Italy;
IRCCS AOU San Martino IST Hyg Unit Genoa Italy;
Univ Hosp Modena Microbiol Unit Modena Italy;
ASST Fatebenefratelli Sacco Univ Hosp Clin Microbiol Virol &
Bioemergencies Milan Italy;
Univ Roma Tor Vergata Dept Expt Med Via Montpellier 1 I-00133 Rome Italy;
Univ Hosp Rome Tor Vergata Infect Dis Rome Italy;
P Giaccone Univ Hosp Gastroenterol Palermo Italy;
Univ Hosp Rome Tor Vergata Hepatol Unit Rome Italy;
Pescara Gen Hosp Infect Dis Unit Pescara Italy;
Univ Sassari Med Surg &
Expt Sci Sassari Italy;
IRCCS Div Internal Med &
Hepatol Humanitas Clin &
Res Ctr Rozzano Italy;
Univ Hosp Messina Dept Internal Med Messina Italy;
Univ Hosp Rome Tor Vergata Infect Dis Rome Italy;
Univ Campania L Vanvitelli Lab Identificat Prognost Factors Response Treatme Naples Italy;
St Andrea Hosp La Sapienza Infect Dis Rome Italy;
IRCCS Policlin Fdn San Matteo Microbiol &
Virol Dept Mol Virol Unit Pavia Italy;
Pescara Gen Hosp Infect Dis Unit Pescara Italy;
IRCCS Children Hosp Bambino Gesu Rome Italy;
Univ Hosp Rome Tor Vergata Hepatol Unit Rome Italy;
P Giaccone Univ Hosp Gastroenterol Palermo Italy;
Univ Hosp Rome Tor Vergata Infect Dis Rome Italy;
Univ Roma Tor Vergata Dept Expt Med Via Montpellier 1 I-00133 Rome Italy;
directamp; 8208; acting antivirals; failure; genotype 3; HCV; resistance;
机译:抗性相关多态性基线试验的成本效益分析,以优化基因型1个非抑菌治疗 - 幼稚患者治疗结果的优化
机译:个体感染丙型肝炎病毒基因型2/3的治疗时间。
机译:丙型肝炎病毒基因型中的个性化治疗持续时间2/3感染患者。
机译:临床治疗慢性乙型肝炎患者乙型肝炎病毒的基因型和血清型鉴定
机译:丙型肝炎病毒感染治疗对患者的影响对阿片类药物使用障碍的影响
机译:使用NS5A耐药性测试来优化对基因1型丙型肝炎病毒的无干扰素口服治疗选择:从意大利国家卫生服务局的角度进行的成本-效用分析
机译:在意大利国家卫生服务部门使用达克他韦治疗肝硬化患者的丙型肝炎病毒(Hcv)基因型3的成本效益分析
机译:南美洲北部发生的甲型肝炎病毒基因型